Image Sourced ShutterStock
Market Herald logo


Be the first with the news that moves the market
  • Job search site ApplyDirect has signed an exclusive three-year deal with the Pharmacy Guild of Australia
  • Pharmacy industry workers will be able to access a digital job search function for new employment across 5,700 pharmacies nation-wide
  • The forthcoming platform will be available online and for Android and iOS

Job search site ApplyDirect has partnered exclusively with the Pharmacy Guild of Australia for a new digitally branded network servicing pharmacy job seekers.

The three-year deal forms the basis for an online and mobile app platform job search for industry workers to seek new employment across the network of community pharmacies.

The Pharmacy Guild of Australia was established in 1928 and currently represents over 5,700 pharmacies across the nation, dispensing an estimated 300 million prescriptions annually.

Pharmacy Guild President George Tambassis says the agreement and forthcoming benefits is an invaluable resource for addressing industry workforce issues,

“Workforce challenges are a major part of the everyday business of community pharmacies and this agreement gives Guild members pharmacists a definitive tool to engage with potential staff and to reduce the costs of doing business associated with recruitment,” he said.

Tambassis also said the agreement is just the latest in offers for members. Today’s news marks the first time an industry association in Australia has partnered with ApplyDirect.

ApplyDirect CEO Bryan Petereit says the deal is the latest in building the company portfolio, including recent wins with the NSW Government, Victoria Government and employment agency Advanced Personal Management.

“These provide the Company with a significant foundation for revenue growth in FY20 as we also continue to build on our sales momentum,” he said.

The company expects associated platform revenue to be launched in the first half of next year, structured on an annual basis.

ApplyDirect’s place in the market remains unchanged today however. Company shares remain at a price of 1.5 cents in a $6.387 million market cap.

AD1 by the numbers
More From The Market Herald
Heramed (ASX:HMD) - CEO and Co Founder, David Groberman

" HeraMED (ASX:HMD) raises $2.39m via convertible note placement

HeraMED (HMD) has raised roughly $2.39 million through a convertible note placement.
ClearVue Technologies (ASX:CPV) - Non Executive Director, John Downes

" ClearVue Technologies (ASX:CPV) appoints LendLease’s John Downes to board

Smart building materials company ClearVue Technologies (CPV) has appointed LendLease’s (LLC) John Downes as Non-Executive Director.
NeuroScientific Biopharmaceuticals (ASX:NSB) - MD and CEO, Matthew Liddelow

" NeuroScientific Biopharmaceuticals (ASX:NSB) completes safety pharmacology studies

NeuroScientific Biopharmaceuticals (NSB) has seen no adverse events during its non-clinical studies of EmtinB.
PharmAust (ASX:PAA) - Chief Scientific Officer, Dr Richard Mollard

" PharmAust (ASX:PAA) identifies optimal MPL dose for canine cancer

Clinical-stage biotech company PharmAust (PAA) has identified the optimum monepantel (MPL) drug plasma range for dogs with B-cell lymphoma.